2017
The IASLC Lung Cancer Staging Project: External Validation of the Revision of the TNM Stage Groupings in the Eighth Edition of the TNM Classification of Lung Cancer
Chansky K, Detterbeck FC, Nicholson AG, Rusch VW, Vallières E, Groome P, Kennedy C, Krasnik M, Peake M, Shemanski L, Bolejack V, Crowley JJ, Asamura H, Rami-Porta R, IASLC Staging and Prognostic Factors Committee A, Goldstraw P, Rami-Porta R, Asamura H, Ball D, Beer D, Beyruti R, Bolejack V, Chansky K, Crowley J, Detterbeck F, Eberhardt W, Edwards J, Galateau-Sallé F, Giroux D, Gleeson F, Groome P, Huang J, Kennedy C, Kim J, Kim Y, Kingsbury L, Kondo H, Krasnik M, Kubota K, Lerut A, Lyons G, Marino M, Marom E, van Meerbeeck J, Mitchell A, Nakano T, Nicholson A, Nowak A, Peake M, Rice T, Rosenzweig K, Ruffini E, Rusch V, Saijo N, Van Schil P, Sculier J, Shemanski L, Stratton K, Suzuki K, Tachimori Y, Thomas C, Travis W, Tsao M, Turrisi A, Vansteenkiste J, Watanabe H, Wu Y, Baas P, Erasmus J, Hasegawa S, Inai K, Kernstine K, Kindler H, Krug L, Nackaerts K, Pass H, Rice D, Falkson C, Filosso P, Giaccone G, Kondo K, Lucchi M, Okumura M, Blackstone E, Cavaco F, Barrera E, Arca J, Lamelas I, Obrer A, Jorge R, Ball D, Bascom G, Orozco A, Castro M, Blum M, Chimondeguy D, Cvijanovic V, Defranchi S, de Olaiz Navarro B, Campuzano I, Vidueira I, Araujo E, García F, Fong K, Corral G, González S, Gilart J, Arangüena L, Barajas S, Girard P, Goksel T, Budiño M, Casaurrán G, Blanco J, Hernández J, Rodríguez H, Collantes J, Heras M, Elena J, Jakobsen E, Kostas S, Atance P, Ares A, Liao M, Losanovscky M, Lyons G, Magaroles R, De Esteban Júlvez L, Gorospe M, McCaughan B, Kennedy C, Íñiguez R, Sorribes L, Gozalo S, de Arriba C, Delgado M, Alarcón J, Cuesta J, Park J, Pass H, Fernández M, Rosenberg M, Ruffini E, Rusch V, de Cos Escuín J, Vinuesa A, Mitjans M, Strand T, Subotic D, Swisher S, Terra R, Thomas C, Tournoy K, Van Schil P, Velasquez M, Wu Y, Yokoi K. The IASLC Lung Cancer Staging Project: External Validation of the Revision of the TNM Stage Groupings in the Eighth Edition of the TNM Classification of Lung Cancer. Journal Of Thoracic Oncology 2017, 12: 1109-1121. PMID: 28461257, DOI: 10.1016/j.jtho.2017.04.011.Peer-Reviewed Original ResearchOrganization, Teamwork and Quality of Care in Thoracic Surgery A Model for High Reliability Care Delivery.
Detterbeck FC, Zurich HB, Agarwal R, Blasberg JD, Boffa DJ, Delrossi EP, Finan ME, Hindinger KK, Kim AW, Pierson M. Organization, Teamwork and Quality of Care in Thoracic Surgery A Model for High Reliability Care Delivery. Connecticut Medicine 2017, 81: 5-12. PMID: 29782759.Peer-Reviewed Original ResearchMeSH KeywordsCooperative BehaviorDelivery of Health CareHumansPatient Care TeamQuality of Health CareReproducibility of ResultsThoracic Surgical Procedures
2014
Quality Indicators for the Evaluation of Patients With Lung Cancer
Mazzone PJ, Vachani A, Chang A, Detterbeck F, Cooke D, Howington J, Dodi A, Arenberg D. Quality Indicators for the Evaluation of Patients With Lung Cancer. CHEST Journal 2014, 146: 659-669. PMID: 24700172, PMCID: PMC4694080, DOI: 10.1378/chest.13-2900.Peer-Reviewed Original ResearchConceptsThoracic Oncology NetworkStaging of patientsCare quality indicatorsLung cancerOncology NetworkPerformance status measuresEvaluation of patientsEvidence-based guidelinesLung cancer specialistsCare of patientsAcademic medical centerQuality improvement committeeCessation counselingChest PhysiciansCancer specialistsMedical CenterAmerican CollegeTissue acquisitionMolecular testingStatus measuresPatientsQuality indicatorsCancerStagingImprovement CommitteeITMIG Consensus Statement on the Use of the WHO Histological Classification of Thymoma and Thymic Carcinoma: Refined Definitions, Histological Criteria, and Reporting
Marx A, Ströbel P, Badve SS, Chalabreysse L, Chan JK, Chen G, de Leval L, Detterbeck F, Girard N, Huang J, Kurrer MO, Lauriola L, Marino M, Matsuno Y, Molina TJ, Mukai K, Nicholson AG, Nonaka D, Rieker R, Rosai J, Ruffini E, Travis WD. ITMIG Consensus Statement on the Use of the WHO Histological Classification of Thymoma and Thymic Carcinoma: Refined Definitions, Histological Criteria, and Reporting. Journal Of Thoracic Oncology 2014, 9: 596-611. PMID: 24722150, DOI: 10.1097/jto.0000000000000154.Peer-Reviewed Original ResearchMeSH KeywordsAntigens, CD20CarcinomaCD5 AntigensGlucose Transporter Type 1HumansMucin-1Proto-Oncogene Proteins c-kitReproducibility of ResultsThymomaThymus NeoplasmsWorld Health OrganizationConceptsThymic carcinomaThymic epithelial tumorsB3 thymomaEpithelial tumorsInternational Thymic Malignancy Interest GroupWorld Health Organization classificationPoor interobserver reproducibilityHistological patternOrganization classificationConsensus statementHistological classificationHistological criteriaThymoma subtypesThymomaAtypical typeGrading systemInterobserver reproducibilityTumorsCarcinomaReproducibility studyRefined criteriaMorphological overlapSubtypesVariable proportions
2013
Clinical Statement on the Role of the Surgeon and Surgical Issues Relating to Computed Tomography Screening Programs for Lung Cancer∗
Rocco G, Allen MS, Altorki NK, Asamura H, Blum MG, Detterbeck FC, Dresler CM, Gossot D, Grondin SC, Jaklitsch MT, Mitchell JD, Newton JR, Van Schil PE, Waddell TK, Wood DE. Clinical Statement on the Role of the Surgeon and Surgical Issues Relating to Computed Tomography Screening Programs for Lung Cancer∗. The Annals Of Thoracic Surgery 2013, 96: 357-360. PMID: 23816098, DOI: 10.1016/j.athoracsur.2013.05.067.Peer-Reviewed Original ResearchMeSH KeywordsGlobal HealthHumansLung NeoplasmsMass ScreeningMorbidityReproducibility of ResultsThoracic Surgical ProceduresTomography, X-Ray Computed
2010
High expression of BCL-2 predicts favorable outcome in non-small cell lung cancer patients with non squamous histology
Anagnostou VK, Lowery FJ, Zolota V, Tzelepi V, Gopinath A, Liceaga C, Panagopoulos N, Frangia K, Tanoue L, Boffa D, Gettinger S, Detterbeck F, Homer RJ, Dougenis D, Rimm DL, Syrigos KN. High expression of BCL-2 predicts favorable outcome in non-small cell lung cancer patients with non squamous histology. BMC Cancer 2010, 10: 186. PMID: 20459695, PMCID: PMC2875218, DOI: 10.1186/1471-2407-10-186.Peer-Reviewed Original ResearchMeSH KeywordsAdenocarcinomaAgedBiomarkers, TumorCarcinoma, Large CellCarcinoma, Non-Small-Cell LungCarcinoma, Squamous CellCell DifferentiationCohort StudiesConnecticutFemaleGreeceHumansKaplan-Meier EstimateLung NeoplasmsMaleMiddle AgedNeoplasm StagingPredictive Value of TestsProportional Hazards ModelsProto-Oncogene Proteins c-bcl-2Reproducibility of ResultsRetrospective StudiesRisk AssessmentRisk FactorsTime FactorsTreatment OutcomeUp-RegulationConceptsNon-small cell lung cancer patientsCell lung cancer patientsNon-squamous tumorsLung cancer patientsBcl-2 expressionNSCLC patientsCancer patientsBcl-2Favorable outcomeIndependent cohortSmall cell lung cancer patientsIndependent lower riskNon-squamous histologySubgroup of patientsHigh expressersSquamous cell carcinomaHigh Bcl-2 expressionBcl-2 protein levelsSquamous histologyMedian survivalPrognostic factorsValidation cohortCell carcinomaPathological characteristicsPrognostic stratificationClassification of the Thoroughness of Mediastinal Staging of Lung Cancer
Detterbeck F, Puchalski J, Rubinowitz A, Cheng D. Classification of the Thoroughness of Mediastinal Staging of Lung Cancer. CHEST Journal 2010, 137: 436-442. PMID: 20133290, DOI: 10.1378/chest.09-1378.BooksMeSH KeywordsCarcinoma, Non-Small-Cell LungHumansLung NeoplasmsLymph NodesLymphatic MetastasisMediastinal NeoplasmsMediastinumNeoplasm StagingReproducibility of Results
2007
Lumping, Splitting, and Sorting
Detterbeck FC. Lumping, Splitting, and Sorting. Journal Of Thoracic Oncology 2007, 2: 581-582. PMID: 17607109, DOI: 10.1097/jto.0b013e31807a2fae.Peer-Reviewed Original ResearchCarcinoma, Small CellHumansLung NeoplasmsNeoplasm StagingReproducibility of ResultsSeverity of Illness Index
2006
Clinical Value of the WHO Classification System of Thymoma
Detterbeck FC. Clinical Value of the WHO Classification System of Thymoma. The Annals Of Thoracic Surgery 2006, 81: 2328-2334. PMID: 16731193, DOI: 10.1016/j.athoracsur.2005.11.067.Peer-Reviewed Original ResearchConceptsWHO systemWorld Health Organization histologic classification systemWHO classification systemIndependent prognostic valueDistinct patient groupsHistologic classification systemClinical management decisionsWHO typePrognostic valuePatient groupClinical valueMultivariate analysisClassification systemThymoma
2004
Seeking a Home for a PET, Part 3 Emerging Applications of Positron Emission Tomography Imaging in the Management of Patients With Lung Cancer
Detterbeck FC, Vansteenkiste JF, Morris DE, Dooms CA, Khandani AH, Socinski MA. Seeking a Home for a PET, Part 3 Emerging Applications of Positron Emission Tomography Imaging in the Management of Patients With Lung Cancer. CHEST Journal 2004, 126: 1656-1666. PMID: 15539740, DOI: 10.1378/chest.126.5.1656.Peer-Reviewed Original ResearchMeSH KeywordsCombined Modality TherapyHumansLung NeoplasmsNeoplasm StagingPositron-Emission TomographyPredictive Value of TestsPrognosisReproducibility of ResultsConceptsManagement of patientsLung cancerPET imagingCycles of chemotherapyCompletion of treatmentPossible lung cancerIntensity of uptakePositron emission tomography (PET) imagingEmission Tomography ImagingPositron emission tomographyFurther technologic improvementsInduction therapyPatient outcomesBiological aggressivenessPatientsEmission tomographyTechnologic improvementsTomography imagingStaging approachRadiotherapy treatment fieldCancerTreatment fieldImagingTreatmentPET images